Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05552118 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Speech Performance and Clinic Efficiency With Remote Care Compared With Standard of Care in Adults With a Cochlear Implant in the First 12 Months Post-activation

Study acronym: INSPIRE
StatusActive, Not Recruiting
PhaseNot applicable
SponsorCochlear
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 16, 2026 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 11 of 11 sites
    v12
  2. Minor Site details revised at 1 of 11 sitesv11
  3. Minor Site details revised at 1 of 11 sitesv10
  4. Notable Primary and study completion dates: Dec 2025 to Sep 2026v9 Show 4 more changesShow less
    • Study sites: 10 to 11
    • Interventions: Cochlear Implant CI600 Series, CI500 Series or Freedom Series and Sound processor Nucleus 7 or Kanso 2 (or latest compatible Sound… to Cochlear™ Remote care (Procedure), Compatible Implant Series and Compatible Sound Processors (Device), Standard of care (Procedure)
    • Collaborators: 2 to 3
    • Eligibility criteria expanded, about 5 words
  5. Minor Site details revised at 3 of 10 sitesv8
Show 6 earlier versionsHide 6 earlier versions
  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2024 to Mar 18, 2024
    • Site details revised at 10 of 10 sites
    v7
  2. Notable Start date: Dec 2023 to Feb 2024
    • Primary and study completion dates: Oct 2025 to Dec 2025
    v6
  3. Notable Start date: Sep 2023 to Dec 2023
    • Primary and study completion dates: Jul 2025 to Oct 2025
    • Site details revised at 1 of 10 sites
    v5
  4. Notable Start date: May 2023 to Sep 2023
    • Study sites: 9 to 10
    • Primary and study completion dates: Feb 2025 to Jul 2025
    v4
  5. Notable Start date: Feb 2023 to May 2023
    • Study sites: 8 to 9
    • Primary and study completion dates: Nov 2024 to Feb 2025
    v3
  6. Notable Start date: Nov 2022 to Feb 2023
    • Study sites: 3 to 8
    • Primary and study completion dates: Jun 30, 2024 to Nov 2024
    • Interventions: Cochlear™ Remote care (Procedure), Standard of care (Procedure) to Cochlear Implant CI600 Series, CI500 Series or Freedom Series and Sound processor Nucleus 7 or Kanso 2 (or latest compatible Sound…
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
28 trials monitored
See all monitored trials
The aim of the study is to assess the real-world effectiveness of managing participants within the first year post-activation (between 3 and 12 months) using Cochlear's Remote Care (Remote Check and Remote Assist), as compared with standard in-clinic management. The study captures also the time and costs associated with both models of care to quantify the potential costs savings and efficiency gains possible with delivering Cochlear Implant (CI) aftercare remotely.
Trial Details
NCT Number NCT05552118
Lead Sponsor Cochlear
Collaborators: QbD Clinical, Avania, TFS
Conditions
(from sponsor)
Hearing Loss
Related terms Hearing Loss
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov